Jan 2026· Briefings in Bioinformatics· Vol 27· 0 citations· 67 references
Computer ScienceBiologyMathematicsMedicine
TL;DR
The proposed engGNN is highlighted as a robust, flexible, and interpretable framework for disease classification and biomarker discovery in high-dimensional omics contexts and provides interpretable feature importance scores that facilitate biologically meaningful discoveries, such as pathway enrichment analysis.
Abstract
Omics data, such as transcriptomics, proteomics, and metabolomics, provide critical insights into disease mechanisms and clinical outcomes. However, their high dimensionality, small sample sizes, and intricate biological networks pose major challenges for reliable prediction and meaningful interpretation. Graph Neural Networks (GNNs) offer a promising way to integrate prior knowledge by encoding feature relationships as graphs. Yet, existing methods typically rely solely on either an externally curated feature graph or a data-driven generated one, which limits their ability to capture complementary information. To address this, we propose the external and generated Graph Neural Network (engGNN), a dual-graph framework that jointly leverages both external known biological networks and data-driven generated graphs. Specifically, engGNN constructs a biologically informed undirected feature graph from established network databases and complements it with a directed feature graph derived from tree-ensemble models. This dual-graph design produces more comprehensive embeddings, thereby improving predictive performance and interpretability. Through extensive simulations and real-world applications to gene expression data, engGNN consistently outperforms state-of-the-art baselines. Beyond classification, engGNN provides interpretable feature importance scores that facilitate biologically meaningful discoveries, such as pathway enrichment analysis. Taken together, these results highlight engGNN as a robust, flexible, and interpretable framework for disease classification and biomarker discovery in high-dimensional omics contexts.
A benchmarking study on multiple GNNs on a Protein-Protein Interaction (PPI) network for Kidney Renal Clear Cell Carcinoma and Breast cancer subtype prediction, performing an in-depth investigation of architectures, incorporating skip connections and various data modalities.
Julia Schirmacher, M. C. Maurer, J. M. Metsch et al.· bioRxiv· 0 citations
SGTL-DDA is proposed, a novel graph transformer framework designed to incorporate structural information and domain-specific knowledge from heterogeneous biological information networks (HBINs) that successfully identifies both known therapeutics and novel repositioning candidates, supported by molecular docking result...
Bowei Zhao, Hui Zhao, Yu-An Huang et al.· IEEE transactions on computa...· 0 citations
To provide accurate and helpful insights, healthcare early illness risk prediction requires the integration of diverse multi-omics data. Unlike existing models (MOGONet, ExplainMix, CNNs), X-GCN presents an integrated explainable graph-based framework that combines graph convolution with hierarchical attention in a uni...
Suresh Kulandaivelu, Mohan Mani· Natural Resources for Human...· 0 citations
A key step in the biological interpretation of untargeted metabolomics data is the ranking of compounds by importance, usually using statistical significance or impact on classification as the basis for importance assignment. However, current approaches treat metabolites as independent variables and rarely incorporat...
Francisco Traquete, C. Cordeiro, Marta Sousa Silva et al.· BMC Bioinformatics· 0 citations
MOTIVATION
Network-based drug repurposing leverages the principle that drug effects propagate through protein-protein interaction (PPI) networks similarly to disease perturbations. Graph-based embedding methods exploit this principle by learning low-dimensional representations that capture the network neighborhood of d...
G. A. Conti, J. L. Gómez Chávez, Ernesto Rafael Perez et al.· Computers in Biology and Med...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.